🇺🇸 Locorten in United States

Locorten (flumetasone pivalate) regulatory status in United States.

Marketing authorisations

FDA

  • Marketing authorisation holder: NOVARTIS
  • Status: approved

FDA

  • Application: NDA016379
  • Marketing authorisation holder: NOVARTIS
  • Local brand name: LOCORTEN
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

Locorten in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Locorten approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for Locorten in United States?

NOVARTIS holds the US marketing authorisation.